New data being presented at the 2018 ACC Scientific Sessions explores the clinical impact due to restrictive insurance practices for access to PCSK9 inhibitors
Posted at 3:55 PM, Mar 12, 2018
and last updated 2018-03-12 18:55:33-04
Copyright 2018 Scripps Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.